Serono Canada Inc.
Canadian affiliate of Ares-Serono International. S.A.
Biotechnology company specializing in R&D, marketing, sales and
distribution of biopharmaceutical and diagnostic products.
Competes in reproductive medicine, oncology, endocrine and
immunology specialties.
15-20 studies underway with recombinant fertility and growth
hormones, recombinant interferon-beta, IL-6, somatostatin,
recombinant tumor necrosis factor binding protein. Indications:
male/female infertility, multiple sclerosis, HIV muscle wasting,
gastrointestinal disorders, chronic renal failure.
R&D focusing on reproductive medicine, immunology/oncology, CNS
neurological, endocrine, metabolic and rheumatology specialties.
Company Details
Year Established:
1990
Total Sales ($CDN):
$10,000,000 - $25,000,000
Number of Employees:
18
Company Information
Johanna Hosick
Title:
Executive Administrator
Area of Responsibility:
Administrative Services
Telephone:
(905) 825-9200
Fax:
(905) 825-9449
Email:
Click Here
Susan Mcguigan
Title:
Manager
Area of Responsibility:
Domestic Sales & Marketing
Telephone:
(905) 825-9200
Fax:
(905) 825-9449
Email:
Click Here
Products
Gonal-f
Fertinorm
FertinormHP (Urofollitropin) followed by chorionic gonadotrophin
(hCG) stimulation of follicular development and ovulation.
Profasi
PROFASI HP (chorionic gonadotropin) is indicated for ovulation
induction; treatment of abortion (habitual); infrequent scanty
bleeding; functional sterility; prepubertal cryptorchidism;
delayed adolescence; dwarfish (pituitary); hypogonadotropic
eunuchoidism; selected cases of hypogonadotropic hypogonadism
Serophene
(Clomiphene Citrate) in the treatment of ovulatory failure in
patients desiring pregnancy, whose husbands have adequate sperm
and who have potentially functional hypothalamic-hypophyseal
ovarian systems and adequate endogenous estrogen.
Relisorm
(Gonadorelin Acetate) As a diagnostic test for the evaluation of
the pituitary component of the hypothalamus-pituitary-gonad axis.
Geref
(Sermorelin Acetate) For the evaluation of short children whose
height is at least 2 standard deviations below the mean height
for their chronological age and sex, presenting low basal serum
levels of IGF-1 and IFG-1-BP3 and who have failed to pass the
exercise or the sleep test.
Saizen
For the long term treatment of patients with growth failure due
to inadequate secretion of normal endogenous growth hormone.
Other causes for growth failure should be ruled out.
Stilamin
For the symptomatic treatment of acute bleeding from esophageal
varices. Other treatment options for long-term management of the
condition may be considered, if necessary, once initial control
has been established.
Services
Biotechnology